Diagnosis and treatment of benign prostatic hyperplasia in the elderly.
Mitsuru KajiwaraKensuke NishidaKenshiro TakemotoMitsuru NakaharaPublished in: Nihon rinsho. Japanese journal of clinical medicine (2019)
Elderly people are at a high risk of experiencing problems with drug therapy due to age- related changes in the body, as well as exposure to many medications owing to multiple health problems. Medication-related adverse events are common amongst the elderly. Pharmacotherapy for benign prostatic hyperplasia or overactive bladder can generally im- prove lower urinary tract symptoms, whilst also improving the quality of life. However,;these drugs also have the potential to cause dangerous adverse events. For this reason, a great deal of caution should be taken when prescribing medication for elderly patients who are suffer- ing from lower urinary tract symptoms.
Keyphrases
- lower urinary tract symptoms
- benign prostatic hyperplasia
- mental health
- adverse drug
- healthcare
- middle aged
- community dwelling
- drug induced
- primary care
- public health
- human health
- emergency department
- smoking cessation
- electronic health record
- stem cells
- risk assessment
- climate change
- replacement therapy
- bone marrow
- mesenchymal stem cells
- social media